Complement has been implicated in several neuroinflammatory diseases including Alzheimer’s disease (Guttenplan et al., 2021) and linked with NLRP3 inflammasome activation (Laudisi et al., 2013). The gene discussed is NLRP3; the disease is early-onset autosomal dominant Alzheimer disease.